Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2025 Filed Oct 1, 2025 22:00 UTC |
Powell James NathanielChief Executive Officer
|
GrantClass A Common Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-014463 · marketforms-70881.xml · nonDerivative · entry 1 Powell James Nathaniel · CIK 0002088007 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,446 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 22:00 UTC |
Baluch KhosoDirector
|
PurchaseWarrant (right to buy) · Derivative | 29,415 | Not disclosed Strike: $0.85 | Not disclosed |
DisclosureSEC source: 0001214659-25-012013 · marketforms-70282.xml · derivative · entry 2 Baluch Khoso · CIK 0001686223 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,415 Underlying: Class A Common Stock · 29,415 shares Expires 2027-08-11 F1 · price: The combined purchase price for each share of Class A Common Stock and accompanying two and one-half Class A Common Warrants was $0.85. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 22:00 UTC |
Baluch KhosoDirector
|
PurchaseClass A Common Stock | 11,766 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-25-012013 · marketforms-70282.xml · nonDerivative · entry 1 Baluch Khoso · CIK 0001686223 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,516 F1 · price: The combined purchase price for each share of Class A Common Stock and accompanying two and one-half Class A Common Warrants was $0.85. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 22:00 UTC |
Locklear LisaChief Financial Officer
|
PurchaseWarrant (right to buy) · Derivative | 29,415 | Not disclosed Strike: $0.85 | Not disclosed |
DisclosureSEC source: 0001214659-25-012014 · marketforms-70281.xml · derivative · entry 2 Locklear Lisa · CIK 0001988416 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,415 Underlying: Class A Common Stock · 29,415 shares Expires 2027-08-11 F1 · price: The combined purchase price for each share of Class A Common Stock and accompanying two and one-half Class A Common Warrants was $0.85. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 22:00 UTC |
Locklear LisaChief Financial Officer
|
PurchaseClass A Common Stock | 11,766 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-25-012014 · marketforms-70281.xml · nonDerivative · entry 1 Locklear Lisa · CIK 0001988416 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,964 F1 · price: The combined purchase price for each share of Class A Common Stock and accompanying two and one-half Class A Common Warrants was $0.85. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:45 UTC |
Hajjar Roger JosephDirector
|
GrantClass A Common Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-010574 · marketforms-70112.xml · nonDerivative · entry 1 Hajjar Roger Joseph · CIK 0002032469 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,000 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 19:44 UTC |
Motwani Neha J.Director
|
GrantClass A Common Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-010567 · marketforms-70114.xml · nonDerivative · entry 1 Motwani Neha J. · CIK 0002031045 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,000 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:44 UTC |
Ungaro UrsulaDirector
|
GrantClass A Common Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-010566 · marketforms-70116.xml · nonDerivative · entry 1 Ungaro Ursula · CIK 0001865511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,000 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:45 UTC |
Baluch KhosoDirector
|
GrantClass A Common Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-010570 · marketforms-70111.xml · nonDerivative · entry 1 Baluch Khoso · CIK 0001686223 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,750 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:47 UTC |
Hare JoshuaDirector · Chief Scientific Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 109,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001214659-25-010577 · marketforms-70105.xml · derivative · entry 1 Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,000 Underlying: Class A Common Stock · 109,000 shares Expires 2035-07-15 F1 · derivative.exercise_date: The option vests quarterly over a three year period beginning on October 1, 2025. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 19:44 UTC |
Kender Richard NDirector
|
GrantClass A Common Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-010568 · marketforms-70113.xml · nonDerivative · entry 1 Kender Richard N · CIK 0001381205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,000 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:46 UTC |
Soffer RockDirector
|
GrantClass A Common Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-010576 · marketforms-70115.xml · nonDerivative · entry 1 Soffer Rock · CIK 0001845308 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,034 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. F3 · balance_after: Share amounts include 41,010 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:46 UTC |
Agafonova NataliyaChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 34,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001214659-25-010575 · marketforms-70106.xml · derivative · entry 2 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,000 Underlying: Class A Common Stock · 34,000 shares Expires 2035-07-15 F3 · derivative.exercise_date: The option vests quarterly over a three year period beginning on October 1, 2025. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:46 UTC |
Agafonova NataliyaChief Medical Officer
|
GrantClass A Common Stock | 102,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-010575 · marketforms-70106.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,697 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:45 UTC |
Lehr Paul TGeneral Counsel, Secretary
|
GrantStock Option (right to buy) · Derivative | 34,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001214659-25-010573 · marketforms-70108.xml · derivative · entry 2 Lehr Paul T · CIK 0001845674 · General Counsel, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,000 Underlying: Class A Common Stock · 34,000 shares Expires 2035-07-15 F3 · derivative.exercise_date: The option vests quarterly over a three year period beginning on October 1, 2025. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:45 UTC |
Lehr Paul TGeneral Counsel, Secretary
|
GrantClass A Common Stock | 102,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-010573 · marketforms-70108.xml · nonDerivative · entry 1 Lehr Paul T · CIK 0001845674 · General Counsel, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,073 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:45 UTC |
Locklear LisaChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 34,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001214659-25-010572 · marketforms-70109.xml · derivative · entry 2 Locklear Lisa · CIK 0001988416 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,000 Underlying: Class A Common Stock · 34,000 shares Expires 2035-07-15 F3 · derivative.exercise_date: The option vests quarterly over a three year period beginning on October 1, 2025. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:45 UTC |
Locklear LisaChief Financial Officer
|
GrantClass A Common Stock | 102,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-010572 · marketforms-70109.xml · nonDerivative · entry 1 Locklear Lisa · CIK 0001988416 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,198 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:45 UTC |
Blass DevinCTO & SVP of CMC
|
GrantStock Option (right to buy) · Derivative | 34,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001214659-25-010571 · marketforms-70110.xml · derivative · entry 2 Blass Devin · CIK 0002046738 · CTO & SVP of CMC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,000 Underlying: Class A Common Stock · 34,000 shares Expires 2035-07-15 F3 · derivative.exercise_date: The option vests quarterly over a three year period beginning on October 1, 2025. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:45 UTC |
Blass DevinCTO & SVP of CMC
|
GrantClass A Common Stock | 102,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-010571 · marketforms-70110.xml · nonDerivative · entry 1 Blass Devin · CIK 0002046738 · CTO & SVP of CMC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,485 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:44 UTC |
Hashad Mohamed Wa'el AhmedChief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001214659-25-010569 · marketforms-70107.xml · derivative · entry 2 Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Class A Common Stock · 60,000 shares Expires 2035-07-15 F3 · derivative.exercise_date: The option vests quarterly over a three year period beginning on October 1, 2025. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 23:44 UTC |
Hashad Mohamed Wa'el AhmedChief Executive Officer
|
GrantClass A Common Stock | 180,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-010569 · marketforms-70107.xml · nonDerivative · entry 1 Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,904 F1 · shares: Represents the award of time-based vesting Restricted Stock Units (RSUs). F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 22:00 UTC |
Hare JoshuaDirector · Chief Scientific Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 49,219 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001214659-25-010056 · marketforms-70037.xml · derivative · entry 1 Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,219 Underlying: Class A Common Stock · 49,219 shares Expires 2035-07-01 F1 · derivative.exercise_date: The option fully vested on the grant date of July 1, 2025. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 22:00 UTC |
Locklear LisaChief Financial Officer
|
Tax withholdingClass A Common Stock | 7,431 | $1.28 | $9,511.68 |
DisclosureSEC source: 0001214659-25-010061 · marketforms-70065.xml · nonDerivative · entry 1 Locklear Lisa · CIK 0001988416 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,198 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit (RSU) award. F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 22:00 UTC |
Blass DevinCTO & SVP of CMC
|
Tax withholdingClass A Common Stock | 4,599 | $1.28 | $5,886.72 |
DisclosureSEC source: 0001214659-25-010059 · marketforms-70062.xml · nonDerivative · entry 1 Blass Devin · CIK 0002046738 · CTO & SVP of CMC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,485 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit (RSU) award. F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 22:00 UTC |
Hashad Mohamed Wa'el AhmedChief Executive Officer
|
Tax withholdingClass A Common Stock | 13,146 | $1.28 | $16,826.88 |
DisclosureSEC source: 0001214659-25-010058 · marketforms-70063.xml · nonDerivative · entry 1 Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,904 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit (RSU) award. F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 22:00 UTC |
Agafonova NataliyaChief Medical Officer
|
Tax withholdingClass A Common Stock | 7,431 | $1.28 | $9,511.68 |
DisclosureSEC source: 0001214659-25-010060 · marketforms-70061.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,697 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit (RSU) award. F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 22:00 UTC |
Lehr Paul TGeneral Counsel, Secretary
|
Tax withholdingClass A Common Stock | 1,562 | $1.28 | $1,999.36 |
DisclosureSEC source: 0001214659-25-010057 · marketforms-70064.xml · nonDerivative · entry 1 Lehr Paul T · CIK 0001845674 · General Counsel, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,073 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit (RSU) award. F2 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 22:00 UTC |
Lehr Paul TGeneral Counsel, Secretary
|
Tax withholdingClass A Common Stock | 64,158 | $1.15 | $73,781.70 |
DisclosureSEC source: 0001214659-25-009623 · marketforms-69985.xml · nonDerivative · entry 2 Lehr Paul T · CIK 0001845674 · General Counsel, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,635 F2 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of an RSU award. F3 · balance_after: Includes RSUs subject to future vesting. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 22:00 UTC |
Lehr Paul TGeneral Counsel, Secretary
|
GrantClass A Common Stock | 163,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-009623 · marketforms-69985.xml · nonDerivative · entry 1 Lehr Paul T · CIK 0001845674 · General Counsel, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 319,793 F1 · shares: Represents an award of restricted stock units (RSUs), which fully and completely vested on the grant date of June 23, 2025. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 22:00 UTC Amendment |
Hare JoshuaDirector · Chief Scientific Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 71,254 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001214659-25-009326 · marketforms-69947.xml · derivative · entry 1 Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,254 Underlying: Common Stock · 71,254 shares Expires 2035-03-04 F1 · derivative.exercise_date: The option will 100% cliff vest on July 1, 2025. The option was administratively granted on March 4, 2025 contingent on stockholder approval at the 2025 Annual Meeting of Stockholders (the "Annual Meeting"). This Form 4/A re-reports an option disclosed in a previous Form 4, filed on March 6, 2025 to (i) correct the transaction date, which was mistakenly reported as March 4, 2025 and (ii) report that the stockholder approval contingency relating to an increase in the number of shares available for awards under the Company's 2021 Incentive Award Plan (as amended and restated to date) was satisfied upon approval of the share increase at the Annual Meeting held on June 13, 2025. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 22:00 UTC |
Hare JoshuaDirector · Chief Scientific Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 184,878 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001214659-25-009325 · marketforms-69943.xml · derivative · entry 1 Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,878 Underlying: Common Stock · 184,878 shares Expires 2035-04-11 F1 · derivative.exercise_date: The option will 100% cliff vest on July 1, 2025. The option was administratively granted on April 11, 2025 contingent on the approval by the Company's stockholders of an amendment to the Company's 2021 Incentive Award Plan (as amended and restated to date) (the "Plan") to increase the number of shares available for awards under the Plan at the 2025 Annual Meeting of Stockholders held on June 13, 2025 (the "Annual Meeting"). This stockholder approval contingency was satisfied upon approval of the share increase at the Annual Meeting. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 22:00 UTC |
Soffer RockDirector
|
SaleClass A Common Stock | 11,000 | $1.25 | $13,750.00 |
DisclosureSEC source: 0001214659-25-008715 · marketforms-69755.xml · nonDerivative · entry 2 Soffer Rock · CIK 0001845308 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,034 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.24 to $1.255, inclusive. The reporting person undertakes to provide to Longeveron Inc., any security holder of Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. F3 · balance_after: Includes RSUs subject to future vesting. F4 · balance_after: Share amounts include 41,010 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:00 UTC |
Soffer RockDirector
|
SaleClass A Common Stock | 10,000 | $1.30 | $13,000.00 |
DisclosureSEC source: 0001214659-25-008715 · marketforms-69755.xml · nonDerivative · entry 1 Soffer Rock · CIK 0001845308 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,034 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.29 to $1.305, inclusive. The reporting person undertakes to provide to Longeveron Inc., any security holder of Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 22, 2025 Filed May 27, 2025 22:52 UTC |
Soffer RockDirector
|
SaleClass A Common Stock | 2,000 | $1.32 | $2,640.00 |
DisclosureSEC source: 0001214659-25-008397 · marketforms-69683.xml · nonDerivative · entry 1 Soffer Rock · CIK 0001845308 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,034 Read SEC document |
| May 16, 2025 Filed May 16, 2025 22:00 UTC |
Hare JoshuaDirector · Chief Scientific Officer · 10% owner
|
SaleClass A Common Stock | 5,250 | $1.40 | $7,367.33 |
DisclosureSEC source: 0001214659-25-008011 · marketforms-69531.xml · nonDerivative · entry 1 Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 721,796 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.40 to $1.42, inclusive. The reporting person undertakes to provide to Longeveron Inc., any security holder of Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. F2 · balance_after: Includes RSUs subject to future vesting. F3 · balance_after: Amount includes 462,807 shares of Class B common stock, which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B common stock have identical rights to holders of common stock, except that holders of Class B common stock are entitled to 5 votes for each share held of record. Each share of Class B common stock is convertible at any time, at the option of the holder, into one share of common stock. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 22:00 UTC |
Locklear LisaChief Financial Officer
|
Tax withholdingClass A Common Stock | 7,566 | $1.50 | $11,349.00 |
DisclosureSEC source: 0001214659-25-005399 · marketforms-69106.xml · nonDerivative · entry 1 Locklear Lisa · CIK 0001988416 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,629 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 22:00 UTC |
Agafonova NataliyaChief Medical Officer
|
Tax withholdingClass A Common Stock | 7,566 | $1.50 | $11,349.00 |
DisclosureSEC source: 0001214659-25-005400 · marketforms-69103.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,128 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 22:00 UTC |
Hashad Mohamed Wa'el AhmedChief Executive Officer
|
Tax withholdingClass A Common Stock | 13,384 | $1.50 | $20,076.00 |
DisclosureSEC source: 0001214659-25-005398 · marketforms-69104.xml · nonDerivative · entry 1 Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,050 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 22:00 UTC |
Lehr Paul TGeneral Counsel, Secretary
|
Tax withholdingClass A Common Stock | 1,599 | $1.50 | $2,398.50 |
DisclosureSEC source: 0001214659-25-005397 · marketforms-69105.xml · nonDerivative · entry 1 Lehr Paul T · CIK 0001845674 · General Counsel, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,750 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 23:00 UTC |
Hare JoshuaDirector · Chief Scientific Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 71,254 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001214659-25-004003 · marketforms-68647.xml · derivative · entry 1 Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,254 Underlying: Common Stock · 71,254 shares Expires 2035-03-04 F1 · derivative.exercise_date: The option will 100% cliff vest on July 1, 2025, following the 2025 Annual Stockholders Meeting, wherein approval is given to increase the pool of shares available for awards under the Plan. In the event stockholder approval is not received at the 2025 meeting, then this option will not in any cirumstances vest until such time as additional shares are added to, and made available under the Second Amended and Restated 2021 Incentive Award Plan. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:15 UTC |
Hashad Mohamed Wa'el AhmedChief Executive Officer
|
Tax withholdingClass A Common Stock | 10,827 | $1.79 | $19,380.33 |
DisclosureSEC source: 0001214659-25-000230 · marketforms-67759.xml · nonDerivative · entry 1 Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,434 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:15 UTC |
Agafonova NataliyaChief Medical Officer
|
Tax withholdingClass A Common Stock | 6,120 | $1.79 | $10,954.80 |
DisclosureSEC source: 0001214659-25-000231 · marketforms-67760.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,694 F1 · shares: Shares withheld to satisfy tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:14 UTC |
Lehr Paul TGeneral Counsel, Secretary
|
Tax withholdingClass A Common Stock | 1,205 | $1.79 | $2,156.95 |
DisclosureSEC source: 0001214659-25-000228 · marketforms-67757.xml · nonDerivative · entry 1 Lehr Paul T · CIK 0001845674 · General Counsel, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,349 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 00:15 UTC |
Locklear LisaChief Financial Officer
|
Tax withholdingClass A Common Stock | 6,120 | $1.79 | $10,954.80 |
DisclosureSEC source: 0001214659-25-000229 · marketforms-67758.xml · nonDerivative · entry 1 Locklear Lisa · CIK 0001988416 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,195 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 23:00 UTC |
Baluch KhosoDirector
|
SaleClass A Common Stock | 1,250 | $2.07 | $2,588.13 |
DisclosureSEC source: 0001214659-24-019977 · marketforms-67491.xml · nonDerivative · entry 1 Baluch Khoso · CIK 0001686223 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,750 F1 · balance_after: A previously filed Form 4 mistakenly under-reported the level of Class A Common Stock owned, as the amount did not account for the one-for-ten stock split that occurred in April 2024 otherwise under-reported by 125 shares. The under-reporting was the result of another previously filed Form 4 which mistakenly reported a disposition of these shares for tax purposes. Thus, the reporting person beneficially owned 25,000 shares of Class A Common Stock before the December 2, 2024 sale reported in this Form 4, which is accounted for in the amount reported in this column 5. F2 · balance_after: Includes Restricted Stock Units (RSUs) subject to future vesting. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:30 UTC |
Locklear LisaChief Financial Officer
|
Tax withholdingClass A Common Stock | 5,316 | $1.88 | $9,994.08 |
DisclosureSEC source: 0001214659-24-017155 · marketforms-67125.xml · nonDerivative · entry 1 Locklear Lisa · CIK 0001988416 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,315 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:30 UTC |
Agafonova NataliyaChief Medical Officer
|
Tax withholdingClass A Common Stock | 5,316 | $1.88 | $9,994.08 |
DisclosureSEC source: 0001214659-24-017154 · marketforms-67126.xml · nonDerivative · entry 1 Agafonova Nataliya · CIK 0001985443 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,814 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:30 UTC |
Lehr Paul TGeneral Counsel, Secretary
|
Tax withholdingClass A Common Stock | 990 | $1.88 | $1,861.20 |
DisclosureSEC source: 0001214659-24-017153 · marketforms-67121.xml · nonDerivative · entry 1 Lehr Paul T · CIK 0001845674 · General Counsel, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,554 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:30 UTC |
Hashad Mohamed Wa'el AhmedChief Executive Officer
|
Tax withholdingClass A Common Stock | 13,357 | $1.88 | $25,111.16 |
DisclosureSEC source: 0001214659-24-017152 · marketforms-67124.xml · nonDerivative · entry 1 Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,261 F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award. F2 · balance_after: Includes Restricted Stock Units subject to future vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.